Original Research
Published on 14 Aug 2020
Overview and Analysis of the Cost of Drug Programs in Poland: Public Payer Expenditures and Coverage of Cancer and Non-Neoplastic Diseases Related Drug Therapies from 2015–2018 Years
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2020.01123
- 10,294 views
- 25 citations
